From Name

From Email

To Name

To Email

Message

Risk-stratified treatments may offer cures in relapsed pediatric anaplastic large cell lymphoma

from Hematology Advisor

Risk-stratified treatments may offer cures in relapsed pediatric anaplastic large cell lymphoma Hematology Advisor A prospective trial of risk-stratified treatment of relapsed anaplastic large cell lymphoma provides evidence for allogeneic hematopoietic stem cell transplantation as standard consolidation therapy in pediatric patients with progression during frontline therapy or relapse of a CD3-positive ALCL. The study results also support vinblastine monotherapy for the treatment of late relapses. READ MORE

more